Financial Highlights

Year ended or at December 31
(in millions, except per share data and notional value) 2011 2010 Change
1
2011 results include a $646 million non-cash benefit from a tax adjustment primarily due to a revaluation of our deferred tax liabilities.
2
Amounts exclude cash performance bonds and guaranty fund contributions.

All references to volume, notional value and rate per contract information in the text of this document exclude our non-traditional TRAKRS, HuRLO, CME Clearing Europe, CDS and IRS products.

See the 2011 Annual Report on Form 10-K for the company’s forward-looking statements.
Income Statement Data
Total revenues $3,281 $3,004 9%
Operating income 2,021 1,831 10
Income before income taxes 1,936 1,722 12
Net income attributable to CME Group1 1,812 951 90
Earnings per share:
Basic1 $14.35 $14.35 90%
Diluted1 14.31 14.31 90
Balance Sheet Data
Current assets2 $1,612 $1,349 19%
Total assets2 31,425 31,008 1
Current liabilities2 281 743 -62
Total liabilities2 9,803 10,879 -10
Shareholders’ equity 21,552 20,060 7
Other Data
Total trading volume (round turn trades) 3,387 3,078 10%
Total electronic volume (round turn trades) 2,860 2,560 12
Open interest at year end (contracts) 78 85 -8
Notional value of trading volume (in trillions) $1,068 $994 7
Total Trading Volume: 07 - 2,250; 08 - 2,978; 09 - 2,585; 10 - 3,078; 11 - 3,387

Total Trading Volume

(in millions of round turn trades)

Total Revenues: 07 - 1,756; 08 - 2,561; 09 - 2,613; 10 - 3,004; 11 - 3,281

Total Revenues

(in millions of dollars)

Operating Margin: 07 - 60; 08 - 62; 09 - 61; 10 - 61; 11 - 62

Operating Margin

(in percentages)

Net Income Attributable to CME Group: 07 - 659; 08 - 715; 09 - 826; 10 - 951; 11 - 1,812

Net Income
Attributable to CME Group

(in millions of dollars)

Continue to: Financial Milestones